ATE327330T1 - Rekombinante humanisierte antikörper gegen fb5 - Google Patents

Rekombinante humanisierte antikörper gegen fb5

Info

Publication number
ATE327330T1
ATE327330T1 AT95913660T AT95913660T ATE327330T1 AT E327330 T1 ATE327330 T1 AT E327330T1 AT 95913660 T AT95913660 T AT 95913660T AT 95913660 T AT95913660 T AT 95913660T AT E327330 T1 ATE327330 T1 AT E327330T1
Authority
AT
Austria
Prior art keywords
humanized
antibodies
specific antibodies
provides
specific
Prior art date
Application number
AT95913660T
Other languages
English (en)
Inventor
Thomas P Wallace
Francis J Carr
Wolfgang J Rettig
Pilar Garin-Chesa
Lloyd J Old
William J Harris
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Application granted granted Critical
Publication of ATE327330T1 publication Critical patent/ATE327330T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT95913660T 1994-03-08 1995-03-08 Rekombinante humanisierte antikörper gegen fb5 ATE327330T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20777894A 1994-03-08 1994-03-08

Publications (1)

Publication Number Publication Date
ATE327330T1 true ATE327330T1 (de) 2006-06-15

Family

ID=22771976

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95913660T ATE327330T1 (de) 1994-03-08 1995-03-08 Rekombinante humanisierte antikörper gegen fb5

Country Status (8)

Country Link
US (4) US5811522A (de)
EP (1) EP0746613B1 (de)
AT (1) ATE327330T1 (de)
AU (1) AU688880B2 (de)
CA (1) CA2185116A1 (de)
DE (1) DE69535002T2 (de)
DK (1) DK0746613T3 (de)
WO (1) WO1995024483A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342757A (en) * 1992-11-13 1994-08-30 Ludwig Institute For Cancer Research Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
WO1995024483A1 (en) * 1994-03-08 1995-09-14 Scotgen Biopharmaceuticals, Inc. Recombinant humanized anti-fb5 antibodies
EE200100302A (et) * 1998-12-02 2002-08-15 Pfizer Products Inc. Meetodid ja kompositsioonid p53 perekonna valgu konformatsioonilise stabiilsuse taastamiseks
EP2039368A3 (de) 1999-04-30 2009-04-01 La Jolla Institute For Allergy And Immunology Verfahren zur Vorbeugung der Reaktivierung von latenten Viren und Überwachung der Virenreplikation
AU2001283062A1 (en) 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns
CA2474497C (en) 2002-01-30 2013-12-03 The Brigham And Women's Hospital, Inc. Compositions and methods related to tim-3, a th1-specific cell surface molecule
US7501494B2 (en) * 2003-01-15 2009-03-10 United Biomedical, Inc. Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection
EP2264073A1 (de) * 2003-03-04 2010-12-22 Kirin Beer Kabushiki Kaisha Endothelzell-spezifische Antikörper und ihre Verwendung
WO2005086713A2 (en) * 2004-03-04 2005-09-22 Kirin Brewery Co., Ltd. Role of human endothelial precursor cells and vascular pericytes tumor in angiogenesis
CN101057145B (zh) 2004-06-23 2014-10-22 得克萨斯系统大学评议会 使用双粒子复合体检测生物分子的方法和组合物
WO2006060719A2 (en) * 2004-12-03 2006-06-08 Morphotek, Inc. Use of endosialin binding proteins to isolate endosialin positive cells
EP1871809A2 (de) 2005-04-22 2008-01-02 Morphotek, Inc. Antikörper mit immuneffektor aktivität die in endosialin positive zellen internalisieren
PT2620451T (pt) * 2007-04-05 2016-12-20 Morphotek Inc Métodos para inibir a ligação da endosialina a ligandos
EA009327B1 (ru) * 2007-04-27 2007-12-28 Петр Генриевич ЛОХОВ Способ получения противоопухолевой вакцины на основе поверхностных антигенов эндотелиальных клеток
WO2008157776A2 (en) * 2007-06-21 2008-12-24 Angelica Therapeutics, Inc. Modified diphtheria toxins
WO2009110944A1 (en) * 2008-02-29 2009-09-11 Angelica Therapeutics, Inc. Modified toxins
JP5839467B2 (ja) * 2009-03-06 2016-01-06 ユニベルシテ パリ デカルト 癌を治療するための方法
US20100260769A1 (en) * 2009-04-09 2010-10-14 Morphotek, Inc. Endosialin binding molecules
US9556272B2 (en) 2009-11-11 2017-01-31 The Trustees Of The University Of Pennsylvania Anti-TEM1 antibodies and uses thereof
US9783610B2 (en) * 2012-04-27 2017-10-10 The Trustees Of The University Of Pennsylvania Anti-tumor endothelial marker-1 (TEM1) antibody variants and uses thereof
HK1220376A1 (zh) 2013-03-15 2017-05-05 Angelica Therapeutics, Inc. 修饰的毒素
EP3194442A4 (de) 2014-09-16 2018-05-23 UBI IP Holdings Behandlung und funktionelle heilung von hiv-infektionen durch monoklonale antikörper gegen cd4 zur vermittlung der kompetitiven hiv-eintrittshemmung
BR112019002734A2 (pt) 2016-08-13 2019-05-14 Ubi Ip Holdings tratamento e remissão virológica sustentada de infecção por hiv por anticorpos para cd4 em pacientes estabilizados por haart

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5225539A (en) * 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5342757A (en) * 1992-11-13 1994-08-30 Ludwig Institute For Cancer Research Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof
WO1995024483A1 (en) * 1994-03-08 1995-09-14 Scotgen Biopharmaceuticals, Inc. Recombinant humanized anti-fb5 antibodies

Also Published As

Publication number Publication date
CA2185116A1 (en) 1995-09-14
AU1996495A (en) 1995-09-25
WO1995024483A1 (en) 1995-09-14
DK0746613T3 (da) 2006-09-25
US6217868B1 (en) 2001-04-17
US5811522A (en) 1998-09-22
US6090930A (en) 2000-07-18
EP0746613B1 (de) 2006-05-24
DE69535002D1 (de) 2006-06-29
AU688880B2 (en) 1998-03-19
EP0746613A1 (de) 1996-12-11
DE69535002T2 (de) 2006-12-07
US6391302B1 (en) 2002-05-21

Similar Documents

Publication Publication Date Title
DE69535002D1 (de) Rekombinante humanisierte antikörper gegen fb5
ATE242326T1 (de) Rekombinante humanisierte antikörper gegen lewis y
NO175944C (no) Monoklonale antistoffer for anvendelse til in vitro påvisning av tumorassosiert mucinantigen, og hybridomcellelinjer som produserer disse
DE69734109D1 (de) Humanisierung von anti-carcinoembryonalen Antigen anti-idiotypischen Antikörper und dessen Verwendung als Tumorvakzin und zur Markierung
DE69841815D1 (de) Anti-VEGF Antikörper
AU1968295A (en) Determination of cancerous conditions by mage gene expression
ATE478952T1 (de) 36p6d5: ausgeschiedenes tumorprotein
EP1097945A3 (de) Für menschlichen Tumornekrose-Faktor spezifische monoklonale und chimäre Antikörper
EP1441766A4 (de) An das krebsassoziierte antigen cd46 bindende antikörper und verwendungsverfahren dafür
ATE171207T1 (de) Monoklonaler antikörper
DE59010418D1 (de) Monoklonale Antikörper (MAK) gegen tumorassoziierte Antigene, ihre Herstellung und Verwendung
ES8900247A1 (es) Un metodo de detecion y diagnostico de cancer empleando un nuevo antigeno asociado a un tumor.
ATE187463T1 (de) Monoklonale antikörper gegen tumorassoziierte antigene, verfahren zu ihrer herstellung und ihre verwendung
ATE288960T1 (de) Humanisierte monoklonale antikörper mit hoher affinität gegen tag-72
NO20004251L (no) Humaniserte anti-CEA monoklonale antistoffer med høy affinitet
NO179328C (no) Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom
IT1264083B1 (it) Procedimento per la produzione in piante di anticorpi ingegnerizzati, anticorpi prodotti e loro uso in diagnosi e terapia.
FI945485A0 (fi) Monoklonaaliset vasta-aineet ja niiden käyttö
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
PT825256E (pt) Celula hibrida e a sua utilizacao para a producao de um farmaco para a inducao de uma imunidade tumoral
AU5790390A (en) A novel tumor associated antigen
SE8401946D0 (sv) Antibody to human prostate cancer
UY25549A1 (es) Metodo para producir un anticuerpo especifico de fap-alfa con productividad mejorada.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0746613

Country of ref document: EP